Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer

(2019) Alok A. Khorana et al.   NEW ENGLAND JOURNAL OF MEDICINE

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

(2019) Nigel S. Key et al.   JOURNAL OF CLINICAL ONCOLOGY

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

(2019) Dominique Farge et al.   LANCET ONCOLOGY

Risk stratification for the development of venous thromboembolism in hospitalized patients with cancer

(2018) A. Parker et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Apixaban for the prevention of venous thromboembolism in high-risk ambulatory cancer patients receiving chemotherapy: Rational and design of the AVERT trial

(2018) Miriam Kimpton et al.   THROMBOSIS RESEARCH

Risk prediction of cancer-associated thrombosis: Appraising the first decade and developing the future

(2018) Alok A. Khorana et al.   THROMBOSIS RESEARCH

A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts

(2018) Ingrid Pabinger et al.   Lancet Haematology

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

(2018) Marc Carrier et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study

(2017) Chiara Alessandra Cella et al.   ONCOLOGIST

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer‐Associated Thrombosis Study

(2017) Grigoris T. Gerotziafas et al.   ONCOLOGIST

Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK)

(2017) Nicole M. Kuderer et al.   ONCOLOGIST

Risk Assessment Scores for Cancer-Associated Venous Thromboembolic Disease

(2017) Dana Angelini et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial

(2017) Saroj Vadhan-Raj et al.   THROMBOSIS AND HAEMOSTASIS

Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial

(2017) Alok A. Khorana et al.   THROMBOSIS RESEARCH

A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality

(2016) Nicole M. Kuderer et al.   ONCOLOGIST

Hypercoagulabilty, venous thromboembolism, and death in patients with cancer

(2016) Florian Posch et al.   THROMBOSIS AND HAEMOSTASIS

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014

(2015) Gary H. Lyman et al.   JOURNAL OF CLINICAL ONCOLOGY

Implementation and validation of a risk stratification method at The Ottawa Hospital to guide thromboprophylaxis in ambulatory cancer patients at intermediate-high risk for venous thrombosis

(2015) Daniel Ben Lustig et al.   THROMBOSIS RESEARCH

Pattern of Frequent But Nontargeted Pharmacologic Thromboprophylaxis for Hospitalized Patients With Cancer at Academic Medical Centers: A Prospective, Cross-Sectional, Multicenter Study

(2014) Jeffrey I. Zwicker et al.   JOURNAL OF CLINICAL ONCOLOGY

Screening high-risk cancer patients for VTE: A prospective observational study

(2014) Alok A. Khorana et al.   THROMBOSIS RESEARCH

Predictors of Venous Thromboembolic Events Associated with Central Venous Port Insertion in Cancer Patients

(2014) Christine Hohl Moinat et al.   Journal of Oncology

Incidence of and Mortality from Venous Thromboembolism in a Real-world Population: The Q-VTE Study Cohort

(2013) Vicky Tagalakis et al.   AMERICAN JOURNAL OF MEDICINE

Lack of Evidence to Support Thromboprophylaxis in Hospitalized Medical Patients with Cancer

(2013) Marc Carrier et al.   AMERICAN JOURNAL OF MEDICINE

Venous Thromboembolism Risk in Patients With Cancer Receiving Chemotherapy: A Real-World Analysis

(2013) G. H. Lyman et al.   ONCOLOGIST

A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score

(2012) Melina Verso et al.   Internal and Emergency Medicine

Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer

(2012) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the ‘SENDO experience’

(2011) M. Mandala` et al.   ANNALS OF ONCOLOGY

High Incidence of Thromboembolic Events in Patients Treated With Cisplatin-Based Chemotherapy: A Large Retrospective Analysis

(2011) Russell A. Moore et al.   JOURNAL OF CLINICAL ONCOLOGY

Prediction of venous thromboembolism in cancer patients

(2010) C. Ay et al.   BLOOD

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

(2009) Giancarlo Agnelli et al.   LANCET ONCOLOGY

Development and validation of a predictive model for chemotherapy-associated thrombosis

(2008) A. A. Khorana et al.   BLOOD